The enteric toxins of Clostridium perfringens

  • J. G. SmedleyIII
  • D. J. Fisher
  • S. Sayeed
  • G. Chakrabarti
  • B. A. McClaneEmail author
Part of the Reviews of Physiology, Biochemistry and Pharmacology book series (REVIEWS, volume 152)


The Gram-positive pathogenClostridium perfringens is a major cause of human and veterinary enteric disease largely because this bacterium can produce several toxins when present inside the gastrointestinal tract. The enteric toxins of C. perfringens share two common features: (1) they are all single polypeptides of modest (~25—35 kDa) size, although lacking in sequence homology, and (2) they generally act by forming pores or channels in plasma membranes of host cells. These enteric toxins include C. perfringens enterotoxin (CPE), which is responsible for the symptoms of a common human food poisoning and acts by forming pores after interacting with intestinal tight junction proteins. Two other C. perfringens enteric toxins, ɛ-toxin (a bioterrorism select agent) and β-toxin, cause veterinary enterotoxemias when absorbed from the intestines; β- and ɛ-toxins then apparently act by forming oligomeric pores in intestinal or extra-intestinal target tissues. The action of a newly discovered C. perfringens enteric toxin, β2 toxin, has not yet been defined but precedent suggests it might also be a pore-former. Experience with other clostridial toxins certainly warrants continued research on these C. perfringens enteric toxins to develop their potential as therapeutic agents and tools for cellular biology.


MDCK Cell Clostridium Perfringens Small Complex Clostridium Perfringens Enterotoxin Rabbit Ileum 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adak GK, Long SM, O’Brien SJ (2002) Trends in indigenous foodborne disease and deaths, England and Wales: 1992 to 2000. Gut 51:832–841PubMedCrossRefGoogle Scholar
  2. Anderson JM, Van Itallie CM (1999) Tight junctions: closing in on the seal. Curr Biol 9:R922–924PubMedCrossRefGoogle Scholar
  3. Bacciarini LN, Pagan O, Frey J, Grone A (2001) Clostridium perfringens β2-toxin in an African elephant (Loxodonta africana) with ulcerative enteritis. Vet Rec 149:618–620PubMedGoogle Scholar
  4. Bacciarini LN, Boerlin P, Straub R, Frey J, Grone A (2003) Immunohistochemical localization of Clostridium perfringens β2-toxin in the gastrointestinal tract of horses. Vet Pathol 40:376–381PubMedCrossRefGoogle Scholar
  5. Bartholomew BA, Stringer MF, Watson GN, Gilbert RJ (1985) Development and application of an enzyme linked immunosorbent assay for Clostridium perfringens type A enterotoxin. J Clin Pathol 38:222–228PubMedCrossRefGoogle Scholar
  6. Beal DR, Titball RW, Lindsay CD (2003) The development of tolerance to Clostridium perfringens type D epsilon-toxin in MDCK and G-402 cells. Hum Exp Toxicol 22:593–605PubMedCrossRefGoogle Scholar
  7. Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH (2003) Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol 5:1051–1061PubMedCrossRefGoogle Scholar
  8. Boise LH, Collins CM (2001) Salmonella-induced cell death: apoptosis, necrosis or programmed cell death? Trends Microbiol 9:64–67PubMedCrossRefGoogle Scholar
  9. Borriello SP, Larson HE, Welch AR, Barclay F, Stringer MF, Bartholomew BA (1984) Enterotoxigenic Clostridium perfringens: a possible cause of antibiotic-associated diarrhoea. Lancet 1:305–307PubMedCrossRefGoogle Scholar
  10. Brennan MA, Cookson BT (2000) Salmonella induces macrophage death by caspase-1-dependent necrosis. Mol Microbiol 38:31–40PubMedCrossRefGoogle Scholar
  11. Brynestad S, Sarker MR, McClane BA, Granum PE, Rood JI (2001) Enterotoxin plasmid from Clostridium perfringens is conjugative. Infect Immun 69:3483–3487PubMedCrossRefGoogle Scholar
  12. Bueschel DM, Jost BH, Billington SJ, Trinh HT, Songer JG (2003) Prevalence of cpb2, encoding β2 toxin, in Clostridium perfringens field isolates: correlation of genotype with phenotype. Vet Microbiol 94:121–129PubMedCrossRefGoogle Scholar
  13. Buxton D (1978) In vitro effects of Clostridium welchii type-D epsilon toxin on guinea-pig, mouse, rabbit and sheep cells. J Med Microbiol 11:299–302PubMedGoogle Scholar
  14. Chakrabarti G, Zhou X, McClane BA (2003) Death pathways activated in CaCo-2 cells by Clostridium perfringens enterotoxin. Infect Immun 71:4260–4270PubMedCrossRefGoogle Scholar
  15. Chakrabarti G, McClane BA (2004) The importance of calcium, calmodulin and calpain for the activation of CaCo-2 cell death pathways by Clostridium perfringens enterotoxin. Cell Microbiol (in press)Google Scholar
  16. Choi DW (1995) Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18:58–60PubMedCrossRefGoogle Scholar
  17. Cole AR, Gibert M, Popoff M, Moss DS, Titball RW, Basak AK (2004) Clostridium perfringens epsilon-toxin shows structural similarity to the pore-forming toxin aerolysin. Nat Struct Mol Biol 11:797–798PubMedCrossRefGoogle Scholar
  18. Collie RE, McClane BA (1998) Evidence that the enterotoxin gene can be episomal in Clostridium perfringens isolates associated with nonfood-borne human gastrointestinal diseases. J Clin Microbiol 36:30–36PubMedGoogle Scholar
  19. Cooney J, Kienle Z, Foster TJ, O’Toole PW (1993) The gamma-hemolysin locus of Staphylococcus aureus comprises three linked genes, two of which are identical to the genes for the F and S components of leukocidin. Infect Immun 61:768–771PubMedGoogle Scholar
  20. Cornillot E, Saint-Joanis B, Daube G, Katayama S, Granum PE, Canard B, Cole ST (1995) The enterotoxin gene (cpe) of Clostridium perfringens can be chromosomal or plasmid-borne. Mol Microbiol 15:639–647PubMedCrossRefGoogle Scholar
  21. Czeczulin JR, Hanna PC, McClane BA (1993) Cloning, nucleotide sequencing, and expression of the Clostridium perfringens enterotoxin gene in Escherichia coli. Infect Immun 61:3429–3439PubMedGoogle Scholar
  22. Daube G, Simon P, Limbourg B, Manteca C, Mainil J, Kaeckenbeeck A (1996) Hybridization of 2,659 Clostridium perfringens isolates with gene probes for seven toxins (alpha, beta, epsilon, iota, theta, mu, and enterotoxin) and for sialidase. Am J Vet Res 57:496–501PubMedGoogle Scholar
  23. Duncan CL (1973) Time of enterotoxin formation and release during sporulation of Clostridium perfringens type A. J Bacteriol 113:932–936PubMedGoogle Scholar
  24. Fernandez Miyakawa ME, Uzal FA (2003) The early effects of Clostridium perfringens type D epsilon toxin in ligated intestinal loops of goats and sheep. Vet Res Commun 27:231–241PubMedCrossRefGoogle Scholar
  25. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S (2000) Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 476:258–261PubMedCrossRefGoogle Scholar
  26. Gibert M, Jolivet-Reynaud C, Popoff MR, Jolivet-Renaud C (1997) Beta2 toxin, a novel toxin produced by Clostridium perfringens. Gene 203:65–73PubMedCrossRefGoogle Scholar
  27. Granum PE, Richardson M (1991) Chymotrypsin treatment increases the activity of Clostridium perfringens enterotoxin. Toxicon 29:898–900PubMedCrossRefGoogle Scholar
  28. Granum PE, Whitaker JR, Skjelkvale R (1981) Trypsin activation of enterotoxin from Clostridium perfringens type A: fragmentation and some physicochemical properties. Biochim Biophys Acta 668:325–332PubMedGoogle Scholar
  29. Hanna PC, McClane BA (1991) A recombinant C-terminal toxin fragment provides evidence that membrane insertion is important for Clostridium perfringens enterotoxin cytotoxicity. Mol Microbiol 5:225–230PubMedCrossRefGoogle Scholar
  30. Hanna PC, Wnek AP, McClane BA (1989) Molecular cloning of the 3′ half of the Clostridium perfringens enterotoxin gene and demonstration that this region encodes receptor-binding activity. J Bacteriol 171:6815–6820PubMedGoogle Scholar
  31. Hanna PC, Mietzner TA, Schoolnik GK, McClane BA (1991) Localization of the receptor-binding region of Clostridium perfringens enterotoxin utilizing cloned toxin fragments and synthetic peptides. The 30 C-terminal amino acids define a functional binding region. J Biol Chem 266:11037–11043PubMedGoogle Scholar
  32. Hanna PC, Wieckowski EU, Mietzner TA, McClane BA (1992) Mapping of functional regions of Clostridium perfringens type A enterotoxin. Infect Immun 60:2110–2104PubMedGoogle Scholar
  33. Hardy SP, Denmead M, Parekh N, Granum PE (1999) Cationic currents induced by Clostridium perfringens type A enterotoxin in human intestinal CaCo-2 cells. J Med Microbiol 48:235–243PubMedGoogle Scholar
  34. Hardy SP, Ritchie C, Allen MC, Ashley RH, Granum PE (2001) Clostridium perfringens type A enterotoxin forms mepacrine-sensitive pores in pure phospholipid bilayers in the absence of putative receptor proteins. Biochim Biophys Acta 1515:38–43PubMedCrossRefGoogle Scholar
  35. Havard HL, Hunter SE, Titball RW (1992) Comparison of the nucleotide sequence and development of a PCR test for the epsilon toxin gene of Clostridium perfringens type B and type D. FEMS Microbiol Lett 76:77–81PubMedCrossRefGoogle Scholar
  36. Hockenbery D (1995) Defining apoptosis. Am J Pathol 146:16–19PubMedGoogle Scholar
  37. Hunter SE, Clarke IN, Kelly DC, Titball RW (1992) Cloning and nucleotide sequencing of the Clostridium perfringens epsilon-toxin gene and its expression in Escherichia coli. Infect Immun 60:102–110PubMedGoogle Scholar
  38. Hunter SE, Brown JE, Oyston PC, Sakurai J, Titball RW (1993) Molecular genetic analysis of beta-toxin of Clostridium perfringens reveals sequence homology with alpha-toxin, gamma-toxin, and leukocidin of Staphylococcus aureus. Infect Immun 61:3958–3965PubMedGoogle Scholar
  39. Jin F, Matsushita O, Katayama S, Jin S, Matsushita C, Minami J, Okabe A (1996) Purification, characterization, and primary structure of Clostridium perfringens lambda-toxin, a thermolysin-like metalloprotease. Infect Immun 64:230–237PubMedGoogle Scholar
  40. Jolivet-Renaud C, Popoff MR, Vinit MA, Ravisse P, Moreau H, Alouf JE (1986) Enteropathogenicity of Clostridium perfringens beta toxin and other clostridial toxins. Zbl. Bakteriol S15:145–151Google Scholar
  41. Katahira J, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N (1997a) Molecular cloning and functional characterization of the receptor for Clostridium perfringens enterotoxin. J Cell Biol 136:1239–1247PubMedCrossRefGoogle Scholar
  42. Katahira J, Sugiyama H, Inoue N, Horiguchi Y, Matsuda M, Sugimoto N (1997b) Clostridium perfringens enterotoxin utilizes two structurally related membrane proteins as functional receptors in vivo. J Biol Chem 272:26652–26658PubMedCrossRefGoogle Scholar
  43. Katayama S, Dupuy B, Daube G, China B, Cole ST (1996) Genome mapping of Clostridium perfringens strains with I-CeuI shows many virulence genes to be plasmid-borne. Mol Gen Genet 251:720–726PubMedGoogle Scholar
  44. Kokai-Kun JF, McClane BA (1997) Deletion analysis of the Clostridium perfringens enterotoxin. Infect Immun 65:1014–1022PubMedGoogle Scholar
  45. Kokai-Kun JF, Benton K, Wieckowski EU, McClane BA (1999) Identification of a Clostridium perfringens enterotoxin region required for large complex formation and cytotoxicity by random mutagenesis. Infect Immun 67:5634–5641PubMedGoogle Scholar
  46. Kumar A, Kumar S, Sarma Dagger PV, Sharma Double Dagger AK (2002) Differential conformational environment of tryptophan in epsilon native prototoxin and active toxin from Clostridium perfringens type D. J Biochem Mol Biol Biophys 6:147–150PubMedCrossRefGoogle Scholar
  47. Labbe RG (1989) Clostridium perfringens. In: Doyle MP (ed) Foodborne bacterial pathogens. Marcel Dekker Press, New York, pp 192–234Google Scholar
  48. Lawrence GW, Lehmann D, Anian G, Coakley CA, Saleu G, Barker MJ, Davis MW (1990) Impact of active immunisation against enteritis necroticans in Papua New Guinea. Lancet 336:1165–1167PubMedCrossRefGoogle Scholar
  49. Liu JW, Porter AG, Wee BY, Thanabalu T (1996) New gene from nine Bacillus sphaericus strains encoding highly conserved 35.8-kilodalton mosquitocidal toxins. Appl Environ Microbiol 62:2174–2176PubMedGoogle Scholar
  50. Long H, Crean CD, Lee WH, Cummings OW, Gabig TG (2001) Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Cancer Res 61:7878–7881PubMedGoogle Scholar
  51. Majno G, Joris I (1995) Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 146:3–15PubMedGoogle Scholar
  52. Matsuda M, Sugimoto N (1979) Calcium-independent and dependent steps in action of Clostridium perfringens enterotoxin on HeLa and Vero cells. Biochem Biophys Res Commun 91:629–636PubMedCrossRefGoogle Scholar
  53. Matsushita O, Yoshihara K, Katayama S, Minami J, Okabe A (1994) Purification and characterization of Clostridium perfringens 120-kilodalton collagenase and nucleotide sequence of the corresponding gene. J Bacteriol 176:149–156PubMedGoogle Scholar
  54. McClane BA, Wnek AP (1990) Studies of Clostridium perfringens enterotoxin action at different temperatures demonstrate a correlation between complex formation and cytotoxicity. Infect Immun 58:3109–3115PubMedGoogle Scholar
  55. McClane BA, Lyerly D, Wilkins T (2000) Enterotoxic Clostridia. In: V. A. Fischetti N, R., Ferretti, J., Portnoy, D., Rood, J. (ed) Gram-Positive Pathogens. ASM Press, Washington, D.CGoogle Scholar
  56. McClane BA, Wnek AP, Hulkower KI, Hanna PC (1988) Divalent cation involvement in the action of Clostridium perfringens type A enterotoxin. Early events in enterotoxin action are divalent cation-independent. J Biol Chem 263:2423–2435PubMedGoogle Scholar
  57. McDonel JL, Dorner F (1986) The role of toxins in bacterial pathogenesis. In: Dorner F, Drews, J. (ed) Pharmacology of Bacterial Toxins. Pergamon Press, Oxford, England; New YorkGoogle Scholar
  58. McDonel JL, Duncan CL (1975) Histopathological effect of Clostridium perfringens enterotoxin in the rabbit ileum. Infect Immun 12:1214–1218PubMedGoogle Scholar
  59. McDonel JL, Chang LW, Pounds JG, Duncan CL (1978) The effects of Clostridium perfringens enterotoxin on rat and rabbit ileum: an electron microscopic study. Lab Invest 39:210–218Google Scholar
  60. Melville SB, Labbe R, Sonenshein AL (1994) Expression from the Clostridium perfringens cpe promoter in C. perfringens and Bacillus subtilis. Infect Immun 62:5550–5558PubMedGoogle Scholar
  61. Michl P, Buchholz M, Rolke M, Kunsch S, Lohr M, McClane B, Tsukita S, Leder G, Adler G, Gress TM (2001) Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121:678–684PubMedCrossRefGoogle Scholar
  62. Minami J, Katayama S, Matsushita O, Matsushita C, Okabe A (1997) Lambda-toxin of Clostridium perfringens activates the precursor of epsilon-toxin by releasing its N-and C-terminal peptides. Microbiol Immunol 41:527–535PubMedGoogle Scholar
  63. Mitic LL, Unger VM, Anderson JM (2003) Expression, solubilization, and biochemical characterization of the tight junction transmembrane protein claudin-4. Protein Sci 12:218–227PubMedCrossRefGoogle Scholar
  64. Miyamoto O, Minami J, Toyoshima T, Nakamura T, Masada T, Nagao S, Negi T, Itano T, Okabe A (1998) Neurotoxicity of Clostridium perfringens epsilon-toxin for the rat hippocampus via the glutamatergic system. Infect Immun 66:2501–2508PubMedGoogle Scholar
  65. Miyamoto O, Sumitani K, Nakamura T, Yamagami S, Miyata S, Itano T, Negi T, Okabe A (2000) Clostridium perfringens epsilon toxin causes excessive release of glutamate in the mouse hippocampus. FEMS Microbiol Lett 189:109–113PubMedCrossRefGoogle Scholar
  66. Miyata S, Matsushita O, Minami J, Katayama S, Shimamoto S, Okabe A (2001) Cleavage of a C-terminal peptide is essential for heptamerization of Clostridium perfringens epsilon-toxin in the synaptosomal membrane. J Biol Chem 276:13778–13783PubMedCrossRefGoogle Scholar
  67. Miyata S, Minami J, Tamai E, Matsushita O, Shimamoto S, Okabe A (2002) Clostridium perfringens epsilon-toxin forms a heptameric pore within the detergent-insoluble microdomains of Madin-Darby canine kidney cells and rat synaptosomes. J Biol Chem 277:39463–39468PubMedCrossRefGoogle Scholar
  68. Nagahama M, Sakurai J (1992) High-affinity binding of Clostridium perfringens epsilon-toxin to rat brain. Infect Immun 60:1237–1240PubMedGoogle Scholar
  69. Nagahama M, Kihara A, Miyawaki T, Mukai M, Sakaguchi Y, Ochi S, Sakurai J (1999) Clostridium perfringens beta-toxin is sensitive to thiol-group modification but does not require a thiol group for lethal activity. Biochim Biophys Acta 1454:97–105PubMedGoogle Scholar
  70. Nagahama M, Morimutsu S, Kihara A, Akita M, Setsu K, Sakurai J (2003) Involvement of tachykinin receptors in Clostridium perfringens beta-toxin-induced plasma extravasation. Br J Pharmacol 138(1):23–30PubMedCrossRefGoogle Scholar
  71. Ohtani K, Kawsar HI, Okumura K, Hayashi H, Shimizu T (2003) The VirR/VirS regulatory cascade affects transcription of plasmid-encoded putative virulence genes in Clostridium perfringens strain 13. FEMS Microbiol Lett 222:137–141PubMedCrossRefGoogle Scholar
  72. Olsen SJ, MacKinnon LC, Goulding JS, Bean NH, Slutsker L (2000) Surveillance for foodborne-disease outbreaks—United States, 1993–1997. MMWR CDC Surveill Summ 49:1–62PubMedGoogle Scholar
  73. Oysten PCF, Paybe DW, Harvard HL, Willianson ED and Titball RW (1998) Production of non-toxic site-directed mutant of Clostridium perfringens-ε-toxin which induces protective immunity in mice. Microbiol 144:333–341CrossRefGoogle Scholar
  74. Petit L, Maier E, Gibert M, Popoff MR, Benz R (2001) Clostridium perfringens epsilon toxin induces a rapid change of cell membrane permeability to ions and forms channels in artificial lipid bilayers. J Biol Chem 276:15736–15740PubMedCrossRefGoogle Scholar
  75. Petit L, Gibert M, Gourch A, Bens M, Vandewalle A, Popoff MR (2003) Clostridium perfringens epsilon toxin rapidly decreases membrane barrier permeability of polarized MDCK cells. Cell Microbiol 5:155–164PubMedCrossRefGoogle Scholar
  76. Richardson M, Granum PE (1983) Sequence of the amino-terminal part of enterotoxin from Clostridium perfringens type A: identification of points of trypsin activation. Infect Immun 40:943–949PubMedGoogle Scholar
  77. Sakurai J (1995) Toxins of Clostridium perfringens. Rev Med Microbiol 6:175–185Google Scholar
  78. Sakurai J, Duncan CL (1978) Some properties of beta-toxin produced by Clostridium perfringens type C. Infect Immun 21:678–680PubMedGoogle Scholar
  79. Sakurai J, Fujii Y (1987) Purification and characterization of Clostridium perfringens beta toxin. Toxicon 25:1301–1310PubMedCrossRefGoogle Scholar
  80. Sakurai J, Nagahama M (1985) Role of one tryptophan residue in the lethal activity of Clostridium perfringens epsilon toxin. Biochem Biophys Res Commun 128:760–766PubMedGoogle Scholar
  81. Sakurai J, Nagahama M (1986) Amino groups in Clostridium perfringens epsilon prototoxin and epsilon toxin. Microb Pathog 1:417–423PubMedCrossRefGoogle Scholar
  82. Sarker MR, Carman RJ, McClane BA (1999) Inactivation of the gene (cpe) encoding Clostridium perfringens enterotoxin eliminates the ability of two cpe-positive C. perfringens type A human gastrointestinal disease isolates to affect rabbit ileal loops. Mol Microbiol 33:946–958PubMedCrossRefGoogle Scholar
  83. Shatursky O, Bayles R, Rogers M, Jost BH, Songer JG, Tweten RK (2000) Clostridium perfringens beta-toxin forms potential-dependent, cation-selective channels in lipid bilayers. Infect Immun 68(10):5546–5551PubMedCrossRefGoogle Scholar
  84. Sherman S, Klein E, McClane BA (1994) Clostridium perfringens type A enterotoxin induces tissue damage and fluid accumulation in rabbit ileum. J Diarrhoeal Dis Res 12:200–207PubMedGoogle Scholar
  85. Shimizu T, Ohtani K, Hirakawa H, Ohshima K, Yamashita A, Shiba T, Ogasawara N, Hattori M, Kuhara S, Hayashi H (2002) Complete genome sequence of Clostridium perfringens, an anaerobic flesh-eater. Proc Natl Acad Sci 99:996–1001PubMedCrossRefGoogle Scholar
  86. Singh U, Van Itallie CM, Mitic LL, Anderson JM, McClane BA (2000) CaCo-2 cells treated with Clostridium perfringens enterotoxin form multiple large complex species, one of which contains the tight junction protein occludin. J Biol Chem 275:18407–18417PubMedCrossRefGoogle Scholar
  87. Singh U, Mitic LL, Wieckowski EU, Anderson JM, McClane BA (2001) Comparative biochemical and immunocytochemical studies reveal differences in the effects of Clostridium perfringens enterotoxin on polarized CaCo-2 cells versus Vero cells. J Biol Chem 276:33402–33412PubMedCrossRefGoogle Scholar
  88. Skjelkvale R, Uemura T (1977) Experimental diarrhoea in human volunteers following oral administration of Clostridium perfringens enterotoxin. J Appl Bacteriol 43:281–286PubMedGoogle Scholar
  89. Songer JG (1996) Clostridial enteric diseases of domestic animals. Clin Microbiol Rev 9:216–234PubMedGoogle Scholar
  90. Steinthorsdottir V, Fridriksdottir V, Gunnarsson E, Andresson OS, Steinporsdottir, Frithriksdottir V (1995) Expression and purification of Clostridium perfringens beta-toxin glutathione S-transferase fusion protein. FEMS Microbiol Lett 130:273–278PubMedCrossRefGoogle Scholar
  91. Steinthorsdottir V, Fridriksdottir V, Gunnarsson E, Andresson OS (1998) Site-directed mutagenesis of Clostridium perfringens beta-toxin: expression of wild-type and mutant toxins in Bacillus subtilis. FEMS Microbiol Lett 158:17–23PubMedCrossRefGoogle Scholar
  92. Steinthorsdottir V, Halldorsson H, Andresson OS (2000) Clostridium perfringens beta-toxin forms multimeric transmembrane pores in human endothelial cells. Micro Pathog 28(1):45–50CrossRefGoogle Scholar
  93. Steller H (1995) Mechanisms and genes of cellular suicide. Science 267:1445–1449PubMedCrossRefGoogle Scholar
  94. Sugimoto N, Takagi M, Ozutsumi K, Harada S, Matsuda M (1988) Enterotoxin of Clostridium perfringens type A forms ion-permeable channels in a lipid bilayer membrane. Biochem Biophys Res Commun 156:551–556PubMedCrossRefGoogle Scholar
  95. Tamai E, Ishida T, Miyata S, Matsushita O, Suda H, Kobayashi S, Sonobe H, Okabe A (2003) Accumulation of Clostridium perfringens epsilon-toxin in the mouse kidney and its possible biological significance. Infect Immun 71:5371–5375PubMedCrossRefGoogle Scholar
  96. Thanabalu T, Porter AG (1996) A Bacillus sphaericus gene encoding a novel type of mosquitocidal toxin of 31.8 kDa. Gene 170:85–89PubMedCrossRefGoogle Scholar
  97. Tweten RK (2001) Clostridium perfringens beta-toxin and Clostridium septicum alpha toxin: their mechanisms and possible role in pathogenesis. Vet Microbiol 82:1–9PubMedCrossRefGoogle Scholar
  98. Waters M, Savoie A, Garmory HS, Bueschel D, Popoff MR, Songer JG, Titball RW, McClane BA, Sarker MR (2003) Genotyping and phenotyping of beta2-toxigenic Clostridium perfringens fecal isolates associated with gastrointestinal diseases in piglets. J Clin Microbiol 41:3584–3591PubMedCrossRefGoogle Scholar
  99. Wen Q, McClane BA (2004) Detection of enterotoxingenic Clostridium perfringens type A isolates in American retail foods. Appl Environ Microbiol 70:2685–2691PubMedCrossRefGoogle Scholar
  100. Wieckowski EU, Wnek AP, McClane BA (1994) Evidence that an approximately 50-kDa mammalian plasma membrane protein with receptor-like properties mediates the amphiphilicity of specifically bound Clostridium perfringens enterotoxin. J Biol Chem 269:10838–10848PubMedGoogle Scholar
  101. Wieckowski EU, Kokai-Kun JF, McClane BA (1998) Characterization of membrane-associated Clostridium perfringens enterotoxin following pronase treatment. Infect Immun 66:5897–5905PubMedGoogle Scholar
  102. Wnek AP, McClane BA (1986) Comparison of receptors for Clostridium perfringens type A and cholera enterotoxins in isolated rabbit intestinal brush border membranes. Microb Pathog 1:89–100PubMedCrossRefGoogle Scholar
  103. Wnek AP, McClane BA (1989) Preliminary evidence that Clostridium perfringens type A enterotoxin is present in a 160,000-Mr complex in mammalian membranes. Infect Immun 57:574–581PubMedGoogle Scholar
  104. Zhao Y, Melville SB (1998) Identification and characterization of sporulation-dependent promoters upstream of the enterotoxin gene (cpe) of Clostridium perfringens. J Bacteriol 180:136–142PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • J. G. SmedleyIII
    • 2
  • D. J. Fisher
    • 2
  • S. Sayeed
    • 2
  • G. Chakrabarti
    • 2
  • B. A. McClane
    • 1
    • 2
    Email author
  1. 1.University of Pittsburgh School of MedicinePittsburghUSA
  2. 2.Department of Molecular Genetics and BiochemistryUniversity of Pittsburgh School of MedicinePittsburghUSA

Personalised recommendations